Home › Funds › Trails Edge Capital Partners, LP › VTVT
Trails Edge Capital Partners, LP position in VTVT
VTV THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 85,192 shares of VTVT (VTV THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.51% of its reported portfolio and ranking #34 among its reported holdings. Trails Edge Capital Partners, LP has disclosed VTVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's VTVT position evolved
Trails Edge Capital Partners, LP first disclosed a stake in VTVT in Q4 2025 at 231,000 shares (US$9.2M). Across 3 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 85,192 shares valued at US$3.2M — a reduction of -54,386 shares quarter over quarter.. Notable position changes include a 40% trim in Q1 2026 (shares fell 5% over the following quarter), a 39% trim in Q2 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 231.00K | $9.24M | New |
| Q1 2026 | 139.58K | $5.54M | Reduce |
| Q2 2026 | 85.19K | $3.21M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTVT and 13F data
VTVT (VTV THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in VTVT — the largest reported positions include Samsara BioCapital, LLC (US$11.2M), Aisling Capital Management LP (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTVT
- Samsara BioCapital, LLC 298.50K sh · $11.24M · Q2 2026
- Aisling Capital Management LP 50.00K sh · $1.88M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held VTVT?
Trails Edge Capital Partners, LP has disclosed VTVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Trails Edge Capital Partners, LP's current position in VTVT?
As of Q2 2026, Trails Edge Capital Partners, LP holds 85.19K shares of VTVT (VTV THERAPEUTICS INC), valued at $3.21M, representing 0.51% of its reported portfolio and ranking #34.
Has Trails Edge Capital Partners, LP been buying or selling VTVT?
In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP reduced its position in VTVT.
Which other funds hold VTVT?
Other major institutional holders of VTVT include Samsara BioCapital, LLC, Aisling Capital Management LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.